Controlling nanocage assembly, towards developing a one-health “plug & play” platform for targeted therapy
Chemical Communications · 2025 · 61 (71) · 13221-13235
DOI: 10.1039/d5cc03592a ↗At a glance
Übersichtsarbeit in Chemical Communications, 2025. Written by Yujie Sheng and 2 co-authors. Institution: Institute of Pharmaceutical Science, King's College London, London, UK. Kourosh.ebrahimi@kcl.ac.uk. Major MEDLINE topics: Ferritins, Nanomedicine, Nanostructures. Cited 5 times so far (Crossref); 145 references. The full text is freely available (open access, CC BY 3.0). Funded by: NCI NIH HHS, Royal Society, Medical Research Council.
Abstract (original language)
We highlight our recent engineering biology approach in creating a one-health ‘plug and play’ nanocage assembly platform for developing multiple therapeutics to target various entities, including viruses, cancer, and bacteria.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute of Pharmaceutical Science, King's College London, London, UK. Kourosh.ebrahimi@kcl.ac.uk.
- UK Health Security Agency, UK.
Funding
- NCI NIH HHS
- Royal Society
- Medical Research Council
- European Cooperation in Science and Technology
Cite
APA
Sheng, Y., Sutton, M. J., & Ebrahimi, K. H. (2025). Controlling nanocage assembly, towards developing a one-health “plug & play” platform for targeted therapy. Chemical Communications, 61(71), 13221-13235. https://doi.org/10.1039/d5cc03592a
Vancouver
Sheng Y, Sutton MJ, Ebrahimi KH. Controlling nanocage assembly, towards developing a one-health “plug & play” platform for targeted therapy. Chemical Communications. 2025;61(71):13221-13235. doi:10.1039/d5cc03592a
BibTeX
@article{Sheng2025,
author = {Sheng, Yujie and Sutton, Mark J and Ebrahimi, Kourosh H},
title = {Controlling nanocage assembly, towards developing a one-health “plug & play” platform for targeted therapy},
journal = {Chemical Communications},
year = {2025},
volume = {61},
number = {71},
pages = {13221--13235},
doi = {10.1039/d5cc03592a}
}
EUVIMED